A Study of Multiple Doses of ALXN2050 in Healthy Adults

NCT05047484 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ALXN2050
DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]